拜欧药业 (837334.OC)

+ 收藏

现金流量表(拜欧药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 130,307,230.12200,639,057.0382,250,854.42225,373,570.16122,376,972.90
 收到其他与经营活动有关的现金(元) 4,869,250.572,913,740.883,675,782.417,003,086.672,090,685.81
 经营活动现金流入小计(元) 135,176,480.69203,552,797.9185,926,636.83232,376,656.83124,467,658.71
 购买商品、接受劳务支付的现金(元) 117,837,117.61168,049,505.2172,543,803.07201,754,028.22107,590,357.14
 支付给职工以及为职工支付的现金(元) 3,812,926.598,342,648.473,897,562.009,700,090.315,554,646.36
 支付的各项税费(元) 642,051.912,769,879.171,410,407.923,894,867.752,140,378.18
 支付其他与经营活动有关的现金(元) 14,910,204.3916,006,605.3013,079,184.3421,587,329.339,660,141.44
 经营活动现金流出小计(元) 137,202,300.50195,168,638.1590,930,957.33236,936,315.61124,945,523.12
 经营活动产生的现金流量净额(元) -2,025,819.818,384,159.76-5,004,320.50-4,559,658.78-477,864.41
二、投资活动产生的现金流量
 收回投资收到的现金(元) ---4,336,827.35-
 取得投资收益收到的现金(元) ---198,721.06198,721.06
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) 3,000.00----
 投资活动现金流入小计(元) 3,000.00--4,535,548.41198,721.06
 购建固定资产、无形资产和其他长期资产支付的现金(元) -116,489.6798,757.5214,595.5714,595.57
 投资支付的现金(元) ---2,716,933.15-
 投资活动现金流出小计(元) -116,489.6798,757.522,731,528.7214,595.57
 投资活动产生的现金流量净额(元) 3,000.00-116,489.67-98,757.521,804,019.69184,125.49
三、筹资活动产生的现金流量
 取得借款收到的现金(元) 12,991,661.6617,276,317.9214,340,000.0037,545,736.965,500,000.00
 筹资活动现金流入小计(元) 12,991,661.6617,276,317.9214,340,000.0037,545,736.965,500,000.00
 偿还债务支付的现金(元) 6,591,071.5023,858,264.079,621,105.4034,555,433.468,000,000.00
 分配股利、利润或偿付利息支付的现金(元) 459,318.691,100,449.28320,728.92759,957.94390,684.69
 支付其他与筹资活动有关的现金(元) 696,846.081,420,292.97733,470.471,401,423.40400,500.00
 筹资活动现金流出小计(元) 7,747,236.2726,379,006.3210,675,304.7936,716,814.808,791,184.69
 筹资活动产生的现金流量净额(元) 5,244,425.39-9,102,688.403,664,695.21828,922.16-3,291,184.69
五、现金及现金等价物净增加额(元) 3,221,605.58-835,018.31-1,438,382.81-1,926,716.93-3,584,923.61
 加:期初现金及现金等价物余额(元) 1,556,499.542,391,517.852,391,517.854,318,234.784,318,234.78
 期末现金及现金等价物余额(元) 4,778,105.121,556,499.54953,135.042,391,517.85733,311.17
补充资料:
 净利润(元) 4,201,394.26-10,314,253.54219,359.26-11,919,775.84-6,641,086.62
 资产减值准备(元) --75,474.59483,598.61-359,635.58
 固定资产和投资性房地产折旧(元) -22,158.84259,153.95123,049.25292,833.87145,755.96
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) -22,158.84259,153.95123,049.25292,833.87145,755.96
 长期待摊费用摊销(元) 12,166.9032,544.0112,166.6277,470.8651,117.44
 处置固定资产、无形资产和其他长期资产的损失(元) ----124,885.29212.49
 公允价值变动损失(元) ---23,865.11-353,954.57
 财务费用(元) 509,318.691,233,146.38320,728.921,042,208.20390,684.69
 投资损失(元) ---2,029,251.631,731,393.54
 递延所得税(元) 351.00122,560.02-18,868.6510,487.059,250.20
  其中:递延所得税资产减少(元) 351.00445,998.06-18,868.6510,487.059,250.20
 递延所得税负债增加(元) --323,438.04---
 存货的减少(元) -5,056,384.551,477,764.78-71,939.442,160,965.69-2,444,050.28
 经营性应收项目的减少(元) 800,278.188,676,356.372,480,919.56-9,206,681.93-550,515.58
 经营性应付项目的增加(元) -3,077,987.175,940,339.09-8,792,116.699,128,333.206,902,618.94
 现金的期末余额(元) 4,778,105.121,556,499.54953,135.042,391,517.85733,311.17
 减:现金的期初余额(元) 1,556,499.542,391,517.852,391,517.854,318,234.784,318,234.78
 现金及现金等价物的净增加额(元) 3,221,605.58-835,018.31-1,438,382.81-1,926,716.93-3,584,923.61
公告日期 2024-07-182024-04-252023-08-242023-04-202022-08-18
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院